Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 9, Pages e76136
Publisher
Public Library of Science (PLoS)
Online
2013-09-27
DOI
10.1371/journal.pone.0076136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
- (2012) Ze-Guang Han Annual Review of Genomics and Human Genetics
- Dual Targeting of the Cyclin/Rb/E2F and Mitochondrial Pathways in Mantle Cell Lymphoma with the Translation Inhibitor Silvestrol
- (2012) L. Alinari et al. CLINICAL CANCER RESEARCH
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma
- (2012) Xiao-Lin Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
- (2011) Andrew X. Zhu et al. CANCER
- Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologies
- (2011) Jens U. Marquardt et al. JOURNAL OF HEPATOLOGY
- The Relevance of Higher Plants in Lead Compound Discovery Programs
- (2011) A. Douglas Kinghorn et al. JOURNAL OF NATURAL PRODUCTS
- The changing pattern of epidemiology in hepatocellular carcinoma
- (2010) Helena Nordenstedt et al. DIGESTIVE AND LIVER DISEASE
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
- (2010) Ju Dong Yang et al. SEMINARS IN CANCER BIOLOGY
- The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
- (2009) David M. Lucas et al. BLOOD
- mTOR inhibitors for hepatocellular cancer: a forward-moving target
- (2009) Gerhard Treiber Expert Review of Anticancer Therapy
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
- (2009) Regina Cencic et al. PLoS One
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started